查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988267

質譜市場：按產品、應用和最終用戶分類－2026-2032年全球市場預測

Mass Spectrometry Market by Product, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，質譜市場價值將達到 64 億美元，到 2026 年將成長至 68.9 億美元，到 2032 年將達到 111.2 億美元，複合年成長率為 8.20%。

主要市場統計數據
基準年 2025 64億美元
預計年份：2026年 68.9億美元
預測年份 2032 111.2億美元
複合年成長率 (%) 8.20%

本策略性介紹概述了當前形勢，即隨著技術的快速發展，質譜技術在臨床診斷研究和工業應用中的作用正在擴大。

質譜技術在分析精度和策略決策方面都處於關鍵地位，對各行各業的實驗室、儀器製造商和終端用戶都至關重要。隨著儀器靈敏度的提高和資料處理技術的日益複雜，相關人員必須使其技術選擇與營運目標、監管要求和不斷變化的應用需求保持一致。本導言概述了重塑該領域的關鍵促進因素，並為後續章節奠定了基礎。後續章節將探討技術轉折點、政策影響、細微的細分市場差異、區域趨勢、競爭格局以及建議措施。

儀器設計、資料科學和整合工作流程的快速發展如何從根本上重塑質譜的競爭格局和應用領域。

隨著技術、數據和工作流程的進步，質譜分析領域正在發生變革，全面重新定義了績效預期和價值提案。儀器層面的最新進展著重提升了解析度和採集速度，使得以往在日常環境中難以實現的分析成為可能。除了硬體改進之外，環境電離技術的進步、樣品製備的簡化以及模組化前端系統的出現，不僅縮短了獲得結果的時間，還拓展了可進行分析的範圍。這些技術進步降低了環境篩檢和食品安全等應用領域的進入門檻，同時也為蛋白質體學和法醫學的更精細分析提供了可能。

評估近期美國關稅措施對質譜生態系統在營運、採購和供應鏈方面的累積影響。

政策和貿易趨勢為分析儀器的採購和供應鏈規劃帶來了新的複雜性。近期政策週期中實施的關稅措施影響了依賴專用質譜儀的實驗室的籌資策略、零件供應和總到岸成本。為此，製造商和採購商正在重新審視其供應商多元化、庫存緩衝和本地組裝策略，以維持服務的連續性並保障長期的研發和測試項目。

透過整合產品應用和最終用戶趨勢的詳細細分洞察，可以揭示客製化設備和軟體策略能夠提供競爭優勢的領域。

對產品、應用和最終用戶細分的精準理解，有助於明確質譜投資能夠帶來差異化價值的領域，以及針對性創新能夠解鎖新功能的領域。基於產品，市場可分為兩大類：「儀器」和「軟體」。儀器類又可細分為氣相層析法聯用（GC-MS）、離子層析法-質譜聯用（IC-MS）、層析法質譜聯用（LC-MS）、基質輔助雷射解吸/飛行時間（MALDI-TOF-MS）及四極桿質譜（Q-MS）。這種產品層面的觀點凸顯了清晰的發展路徑。層析法聯用技術仍是常規定量工作流程的主要驅動力，而MALDI-TOF和高解析度平台則能夠實現快速鑑定和探索性分析。

影響實施支援和商業化路徑的美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和戰略考量。

在全球質譜領域，區域趨勢影響投資重點、監管要求和夥伴關係模式。在美洲，成熟的臨床和製藥生態系統持續推動對經過驗證的高通量平台和整合數據解決方案的需求，而強大的服務市場則支援儀器的長生命週期和分析方法的快速應用。供應商與大型終端用戶之間的關係以捆綁式服務協議為特徵，從而確保關鍵任務的順利運作和本地化的技術支援。

競爭動態和企業策略揭示了軟體服務模型和工作流程驗證如何決定供應商差異化和長期採用率。

質譜領域的競爭格局呈現出老字型大小企業與新興專業公司並存的局面，軟體生態系統、服務模式和檢驗的應用套裝程式日益成為差異化競爭的關鍵促進因素。老牌儀器供應商憑藉著深厚的工程技術和全球服務網路，持續贏得受監管終端用戶的信賴。同時，一些規模較小的公司則專注於模組化設計、快速創新週期以及在細分應用領域的領先地位。硬體可靠性與數據分析能力之間的相互作用，使得夥伴關係與收購成為快速彌補產品組合缺口的關鍵策略。

為產業領導者提供切實可行的建議，以協調採購人才和夥伴關係策略，並加速採用檢驗的質譜工作流程。

希望利用質譜創新技術的領導者應著重於技術、人才和夥伴關係關係的策略整合，以加速價值實現。首先，應優先投資於能夠提供檢驗的工作流程和無縫資料整合的平台，從而縮短行動時間並加強合規性。其次，應透過有針對性的培訓項目以及與學術機構和標準檢測實驗室的合作，拓展內部分析能力，彌合營運差距，​​並推動先進分析方法的開發。此類投資將透過減少對外部服務供應商的依賴和縮短關鍵檢測結果的獲取時間，帶來顯著成效。

技術和商業性見解透過高度透明的調查方法進行檢驗，該方法整合了與相關人員的訪談、供應商材料、監管指南和同行評審的科學文獻。

本摘要的研究整合了對關鍵相關人員的訪談、供應商資料、監管指南和同行評審文獻，旨在建立對技術和商業性趨勢的平衡視角。主要資訊來源包括對臨床、環境和工業檢測機構的實驗室主任、採購負責人和技術負責人進行的結構化訪談，以及與專注於蛋白質組學和法醫學分析的研究型終端用戶的對話。供應商的產品規格和白皮書用於評估儀器性能，而調查方法學論文和標準指南則用於檢驗有關可重複性和應用適用性的說法。

總結了整合儀器數據工作流程和穩健的供應策略如何決定質譜的長期策略價值。

先進設備、以數據為中心的工作流程以及日益增強的供應鏈意識的融合，正在重塑質譜部署的策略決策框架。整合高效能硬體、強大的軟體、檢驗的工作流程和可靠的服務基礎設施的機構，將能夠在診斷研究和工業應用的各個領域實現價值最大化。在這個不斷發展的技術格局中，將儀器層面的改進轉化為營運效率和法規遵從性的能力，正成為實驗室領導者的關鍵技能。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 質譜市場：依產品分類

  • 裝置
    • 氣相層析法和質譜
    • 離子層析法-質譜法
    • 液相層析質譜聯用
    • 基質輔助雷射解吸/電離飛行時間質譜法
    • 四極桿質譜法
  • 軟體

第9章 質譜市場：依應用領域分類

  • 臨床診斷
  • 環境測試
  • 食品和飲料檢查
  • 法醫學
  • 蛋白質體學

第10章 質譜市場：依最終用戶分類

  • 學術和研究機構
  • 環境檢測實驗室
  • 食品飲料業
  • 法醫學研究所
  • 製藥和生物技術公司

第11章 質譜市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 質譜市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 質譜市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 美國質譜市場

第15章 中國質譜市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 908 Devices Inc.
  • Advion, Inc.
  • Agilent Technologies, Inc.
  • AMETEK Inc.
  • Analytik Jena AG
  • Avantor, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • DANI Instruments SpA
  • F. Hoffmann-La Roche AG
  • FLIR Systems, Inc.
  • Hiden Analytical, Inc.
  • Hitachi, Ltd.
  • JEOL Ltd.
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • MKS Instruments, Inc.
  • PerkinElmer, Inc.
  • Pfeiffer Vacuum GmbH
  • Process Insights AG
  • Rigaku Corporation
  • SCIEX AB
  • Shimadzu Corporation
  • Spectrum Chemical Mfg. Corp.
  • Thermo Fisher Scientific Inc.
  • VProteomics Company
  • Waters Corporation
Product Code: MRR-6B77D7DC7872

The Mass Spectrometry Market was valued at USD 6.40 billion in 2025 and is projected to grow to USD 6.89 billion in 2026, with a CAGR of 8.20%, reaching USD 11.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.40 billion
Estimated Year [2026] USD 6.89 billion
Forecast Year [2032] USD 11.12 billion
CAGR (%) 8.20%

A strategic introduction framing the expanding role of mass spectrometry across clinical diagnostics research and industrial applications amid rapid technological evolution

Mass spectrometry stands at the intersection of analytical precision and strategic decision-making for laboratories, instrument manufacturers, and end users across sectors. As instrumentation becomes more sensitive and data handling more sophisticated, stakeholders must align technology choices with operational objectives, regulatory expectations, and evolving application demands. This introduction outlines the core forces reshaping the field and frames the subsequent sections that explore technology inflections, policy impacts, segmentation nuances, regional dynamics, competitive behavior, and recommended actions.

The discipline now spans routine clinical workflows to cutting-edge proteomics and environmental surveillance, demanding versatility from platforms and clarity from decision-makers. With an accelerating pace of methodological innovation and growing demand for reproducible, high-throughput analyses, organizations must reexamine procurement criteria, laboratory design, and talent development. This introductory overview emphasizes that strategic adoption of mass spectrometry requires both technical literacy and a clear alignment to organizational priorities, from regulatory compliance to scientific differentiation. The remainder of this executive summary builds on that premise to deliver actionable insight for leaders preparing to invest in or deploy mass spectrometry capabilities.

How rapid advances in instrument design data science and integrated workflows are fundamentally reshaping the competitive and application landscape for mass spectrometry

The landscape for mass spectrometry is being transformed by a confluence of technical, data, and workflow shifts that collectively redefine performance expectations and value propositions. Recent instrument-level advances emphasize higher resolving power and faster acquisition rates, enabling analyses that were previously impractical in routine settings. Complementing hardware improvements, advances in ambient ionization, simplified sample preparation, and modular front-end systems reduce time to result while widening the range of feasible assays. These technical gains are simultaneously lowering barriers for applications such as environmental screening and food safety while enabling deeper interrogation in proteomics and forensics.

Parallel to instrumentation evolution, software and data science have emerged as pivotal differentiators. Machine learning algorithms and automated spectral interpretation accelerate throughput and reduce operator dependence, while cloud-enabled platforms facilitate collaborative analysis and remote method development. Interoperability between instrument vendors and third-party informatics providers is becoming a competitive imperative. As the ecosystem matures, value shifts from individual instruments to integrated solutions that pair robust hardware with comprehensive data workflows, regulatory-ready reporting, and user-centered interfaces. For organizations, this means procurement decisions increasingly hinge on software roadmaps, lifecycle support, and the vendor's ability to deliver validated workflows rather than on hardware metrics alone.

Assessing the cumulative operational procurement and supply chain consequences of recent United States tariff measures on the mass spectrometry ecosystem

Policy and trade dynamics have introduced new layers of complexity to procurement and supply chain planning for analytical instrumentation. Tariff measures enacted in recent policy cycles have affected sourcing strategies, component availability, and total landed costs for laboratories that rely on specialized mass spectrometry equipment. In response, manufacturers and buyers have reexamined supplier diversification, inventory buffering, and local assembly strategies to maintain continuity of service and protect long-term research and testing programs.

The cumulative effect of these trade actions has been to accelerate certain strategic behaviors among stakeholders. Instrument vendors have intensified efforts to localize key manufacturing steps or secure alternate supply channels for critical optics and electronics. Laboratories are prioritizing lifecycle planning and strengthening service contracts to mitigate the operational risk of delayed deliveries. Procurement teams are engaging earlier with technical and finance stakeholders to evaluate procurement windows and evaluate the trade-offs between faster delivery and specific configuration needs. Overall, the tariff environment has underscored the importance of supply chain resilience and prompted a more strategic approach to vendor selection and contract structuring across the sector.

Granular segmentation insights synthesizing product application and end-user dynamics to reveal where tailored instrument and software strategies create competitive advantage

A refined understanding of product, application, and end-user segmentation clarifies where investments in mass spectrometry deliver differentiated value and where targeted innovation can unlock new capabilities. Based on Product, the market is studied across Instruments and Software, and the Instruments category further differentiates across Gas Chromatography-Mass Spectrometry, Ion Chromatography Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry, and Quadrupole Mass Spectrometry. This product-level view highlights distinct development pathways: chromatographic hyphenation continues to drive routine quantitative workflows, while MALDI-TOF and high-resolution platforms enable rapid identification and discovery-oriented analyses.

Based on Application, the market is studied across Clinical Diagnostics, Environmental Testing, Food & Beverage Testing, Forensics, and Proteomics, revealing divergent performance priorities and validation requirements across use cases. Clinical diagnostics and regulated testing emphasize reproducibility, validated workflows, and perpetual compliance documentation, whereas proteomics and forensics often demand the highest sensitivity and resolution to support novel discovery or evidentiary standards. Based on End User, the market is studied across Academic & Research Institutions, Environmental Testing Labs, Food & Beverage Industry, Forensic Labs, and Pharmaceutical & Biotechnology Firms, each exhibiting unique procurement cycles, budgetary constraints, and in-house expertise profiles. When these segmentation dimensions are considered together, it becomes clear that vendors and laboratory leaders must tailor propositions to the intersection of instrument capability, application rigor, and user sophistication to achieve sustained adoption.

Regional dynamics and strategic considerations across the Americas Europe Middle East and Africa and Asia-Pacific that influence adoption support and commercialization pathways

Regional dynamics are shaping investment priorities, regulatory requirements, and partnership models across the global mass spectrometry landscape. In the Americas, well-established clinical and pharmaceutical ecosystems continue to drive demand for validated, high-throughput platforms and integrated data solutions, while a strong service market supports long instrument lifecycles and rapid method deployment. Relationships between vendors and large-scale end users are characterized by bundled service agreements and localized technical support infrastructure that enable mission-critical operations.

In Europe, Middle East & Africa, heterogeneity across national regulatory regimes and funding environments creates a mosaic of adoption patterns, with some markets prioritizing cutting-edge research instrumentation and others emphasizing cost-effective surveillance and environmental monitoring. Strategic collaborations with centralized reference laboratories and public health agencies are common, enabling technology diffusion and shared method development. In Asia-Pacific, investment is skewed toward capacity expansion and rapid scaling, driven by both private sector R&D and public-sector surveillance initiatives. High-volume manufacturing hubs in the region also influence supply chain considerations and encourage regional OEM partnerships. Across regions, localization of service, regulatory alignment, and the ability to support cross-border workflows are decisive factors in long-term vendor success.

Competitive dynamics and company strategies that reveal how software service models and workflow validation determine vendor differentiation and long-term adoption

Competitive behavior in the mass spectrometry space reflects a mix of legacy incumbents and emergent specialists, with differentiation increasingly driven by software ecosystems, service models, and validated application packages. Established instrument suppliers continue to leverage deep engineering expertise and global service networks to maintain trust among regulated end users, while leaner companies focus on modular designs, rapid innovation cycles, and niche application dominance. The interplay between hardware reliability and data analytics capabilities has elevated partnerships and acquisitions as common strategies to fill portfolio gaps quickly.

From a commercialization perspective, companies that embed workflow automation, regulatory-ready reporting, and open data standards into their product suites gain a meaningful advantage in heavily regulated segments. Meanwhile, providers targeting discovery and high-resolution applications concentrate on extending dynamic range and improving throughput without sacrificing spectral fidelity. Across the vendor landscape, the capacity to provide reproducible methods, comprehensive training, and responsive after-sales support remains a critical differentiator that influences procurement decisions and long-term client retention.

Actionable recommendations for industry leaders to align procurement talent and partnership strategies and accelerate adoption of validated mass spectrometry workflows

Leaders seeking to capitalize on mass spectrometry innovation should focus on strategic alignment across technology, talent, and partnerships to accelerate value realization. First, prioritize investments in platforms that offer validated workflows and seamless data integration to reduce time to usable results and to strengthen regulatory readiness. Second, expand in-house analytical capabilities through targeted training programs and partnerships with academic or reference laboratories to bridge operational gaps and enable advanced method development. Such investments pay dividends by reducing dependency on external service providers and improving time-to-insight for critical assays.

Third, reassess procurement approaches to emphasize supplier resilience and lifecycle support; secure service-level commitments that include parts, calibration, and software updates to safeguard continuity. Fourth, consider collaboration models that pair instrument providers with third-party informatics specialists to accelerate adoption of AI-driven interpretation and automated reporting. Finally, align commercial and R&D roadmaps to prioritize applications with clear clinical or regulatory value, ensuring that new method introductions are accompanied by validation packages and user training to drive uptake in regulated environments.

Transparent research methodology blending stakeholder interviews vendor documentation regulatory guidance and peer-reviewed science to validate technical and commercial insights

The research underpinning this summary synthesizes primary stakeholder interviews, instrument vendor documentation, regulatory guidance, and peer-reviewed literature to create a balanced view of technical and commercial trends. Primary inputs included structured interviews with laboratory directors, procurement officers, and technology leaders across clinical, environmental, and industrial testing sites, supplemented by conversations with research-focused end users specializing in proteomics and forensic analysis. Vendor product specifications and white papers were used to evaluate instrument capabilities, while methodological papers and standards guidance helped validate claims around reproducibility and application fit.

Analytical rigor was maintained through cross-validation of qualitative inputs with publicly available regulatory frameworks and independent scientific literature. Emphasis was placed on identifying repeatable patterns across interviews and documented evidence rather than relying on single-source claims. The resulting synthesis prioritizes actionable insights and preserves methodological transparency to support informed decision-making by executives, scientists, and procurement professionals.

Concluding synthesis on how integrated instrumentation data workflows and resilient supply strategies determine the long-term strategic value of mass spectrometry

The convergence of advanced instrumentation, data-centric workflows, and heightened supply chain awareness is reshaping the strategic calculus for mass spectrometry adoption. Organizations that integrate high-performance hardware with robust software, validated workflows, and dependable service infrastructure will be best positioned to extract value across diagnostics research and industrial applications. As the technology landscape evolves, the ability to translate instrument-level improvements into operational efficiencies and regulatory-compliant results becomes the defining competency for laboratory leaders.

Looking ahead, success will favor those who adopt a systems view-aligning procurement, training, and data strategies to realize the full benefits of next-generation mass spectrometry. By prioritizing interoperability, reproducibility, and supplier resilience, institutions can navigate policy headwinds and technological disruption while unlocking new scientific and commercial opportunities that enhance both short-term performance and long-term strategic positioning.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Mass Spectrometry Market, by Product

  • 8.1. Instruments
    • 8.1.1. Gas Chromatography-Mass Spectrometry
    • 8.1.2. Ion Chromatography Mass Spectrometry
    • 8.1.3. Liquid Chromatography-Mass Spectrometry
    • 8.1.4. Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry
    • 8.1.5. Quadrupole Mass Spectrometry
  • 8.2. Software

9. Mass Spectrometry Market, by Application

  • 9.1. Clinical Diagnostics
  • 9.2. Environmental Testing
  • 9.3. Food & Beverage Testing
  • 9.4. Forensics
  • 9.5. Proteomics

10. Mass Spectrometry Market, by End User

  • 10.1. Academic & Research Institutions
  • 10.2. Environmental Testing Labs
  • 10.3. Food & Beverage Industry
  • 10.4. Forensic Labs
  • 10.5. Pharmaceutical & Biotechnology Firms

11. Mass Spectrometry Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Mass Spectrometry Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Mass Spectrometry Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Mass Spectrometry Market

15. China Mass Spectrometry Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. 908 Devices Inc.
  • 16.6. Advion, Inc.
  • 16.7. Agilent Technologies, Inc.
  • 16.8. AMETEK Inc.
  • 16.9. Analytik Jena AG
  • 16.10. Avantor, Inc.
  • 16.11. Bruker Corporation
  • 16.12. Danaher Corporation
  • 16.13. DANI Instruments S.p.A.
  • 16.14. F. Hoffmann-La Roche AG
  • 16.15. FLIR Systems, Inc.
  • 16.16. Hiden Analytical, Inc.
  • 16.17. Hitachi, Ltd.
  • 16.18. JEOL Ltd.
  • 16.19. Kore Technology Limited
  • 16.20. LECO Corporation
  • 16.21. Merck KGaA
  • 16.22. MKS Instruments, Inc.
  • 16.23. PerkinElmer, Inc.
  • 16.24. Pfeiffer Vacuum GmbH
  • 16.25. Process Insights AG
  • 16.26. Rigaku Corporation
  • 16.27. SCIEX AB
  • 16.28. Shimadzu Corporation
  • 16.29. Spectrum Chemical Mfg. Corp.
  • 16.30. Thermo Fisher Scientific Inc.
  • 16.31. VProteomics Company
  • 16.32. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MASS SPECTROMETRY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MASS SPECTROMETRY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ION CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ION CHROMATOGRAPHY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ION CHROMATOGRAPHY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY QUADRUPOLE MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY QUADRUPOLE MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY QUADRUPOLE MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY ENVIRONMENTAL TESTING LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE INDUSTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE INDUSTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. GCC MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GCC MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. GCC MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 107. GCC MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. GCC MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. G7 MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. G7 MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 121. G7 MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 122. G7 MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. G7 MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NATO MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NATO MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 126. NATO MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 127. NATO MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NATO MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA MASS SPECTROMETRY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA MASS SPECTROMETRY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA MASS SPECTROMETRY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA MASS SPECTROMETRY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA MASS SPECTROMETRY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)